Wasazra Pharmaceuticals Limited
About Wasazra Pharmaceuticals Limited
Data last updated:
Wasazra Pharmaceuticals Limited is a public limited company based in Lucknow, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 01 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PLC093735. Its GSTIN is 09AACCW0173F1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sayed Ahmad Masood Hashmi (Managing Director) and Azra Waseem.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.46 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹12.62 Lakh (net margin 2%) and EBITDA of ₹18.96 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Wasazra Pharmaceuticals Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Social Media
- Registered Address628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Wasazra Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wasazra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wasazra Pharmaceuticals Limited, buy the company report.
Financials of Wasazra Pharmaceuticals Limited
FY 2025 filings availableWasazra Pharmaceuticals Limited reported revenue of ₹6.46 Cr (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.96 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wasazra Pharmaceuticals Limited, buy the company report.
Board of directors of Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sayed Ahmad Masood Hashmi | Managing Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Azra Waseem | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Nida Fatima | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Firdaus Fatima Also directs: Integral Startups Foundation, Ze&H Textiles Private Limited | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Wasazra Pharmaceuticals Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bravo Pharmaceuticals Private Limited | ₹6.47 Cr (FY 2024) | 750.0% | New Delhi, Delhi, India | |||
| Wasazra Pharmaceuticals Limited this company | ₹6.46 Cr (FY 2024) | ₹12.62 Lakh | 2% | -2.0% | Lucknow, Uttar Pradesh, India | |
| Rheo Pharma Private Limited | ₹6.46 Cr (FY 2024) | 525.0% | Hyderabad, Telangana, India | |||
| Tejaswi Biotech Private Limited | ₹6.43 Cr (FY 2025) | -25.0% | Delhi, India |
To see the full peer comparison of Wasazra Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wasazra Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wasazra Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wasazra Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW0173F1ZG | Uttar Pradesh | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of Wasazra Pharmaceuticals Limited, buy the company report.
Recent activity
Wasazra Pharmaceuticals Limited has 6 board changes on record since 2017: 5 appointments and 1 cessation. The latest: Syed Mohammad Fauzan Akhtar ceased to be Managing Director on 14 May 2024.
Frequently asked questions
Wasazra Pharmaceuticals is an active public limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 01 June 2017 (9+ years old) and is registered under CIN U51909UP2017PLC093735.
Wasazra Pharmaceuticals has 4 current directors:
- Sayed Ahmad Masood Hashmi - Managing Director
- Azra Waseem - Director
- Nida Fatima - Director
- Firdaus Fatima - Director
The latest financial statements of Wasazra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Wasazra Pharmaceuticals is 09AACCW0173F1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Wasazra Pharmaceuticals is U51909UP2017PLC093735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wasazra Pharmaceuticals was incorporated on 01 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Wasazra Pharmaceuticals by revenue are Bravo Pharmaceuticals Private Limited, Rheo Pharma Private Limited, Tejaswi Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Syed Mohammad Fauzan Akhtar ceased to be Managing Director on 14 May 2024. Syed Mohammad Fauzan Akhtar was appointed as Managing Director on 28 Jun 2017. Azra Waseem was appointed as Director on 01 Jun 2017. Wasazra Pharmaceuticals has 6 board changes on record in total.
The registered office of Wasazra Pharmaceuticals is at 628C30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016.
Wasazra Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Wasazra Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.